Delivering myeloma expertise to caregivers everywhere

myelomaMinBannerTemplate3.15.png

| INNOVATION | Latest Research

490x245science.png

IMF Launches New Education Initiative for Those on the Frontlines of Patient Care

Busy healthcare providers need up-to-date expert recommendations delivered in convenient formats to best treat myeloma patients. With the launch of a new education initiative, the IMF will be there for them.

LearnMoreButton.png

| EMPOWERMENT | Action

200x200MAM.png

| EDUCATION | Event

Nashville200x200.png

What Does It Mean to Be a Myeloma Warrior?

Regional Community Workshop in Nashville

In this video, patient, caregivers, and healthcare professionals answer the question, “What does it mean to be a myeloma warrior?” Watch now to hear their perspectives on such topics as self-advocating as a patient, finding hope, educating yourself, living fearlessly, and paving the path towards a cure.

The IMF will host a Regional Community Workshop in Nashville on Saturday, April 21, 2018. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Ed Libby, MD (Seattle Cancer Care Alliance, Seattle), Craig Cole, MD (University of Michigan, Ann Arbor, MI), Frank Cornell, MD (Vanderbilt University, Nashville, TN) and Kevin Brigle, PhD, NP (Virginia Commonwealth University, Richmond, VA).

ViewButton.png

registerNowButton.png

| INNOVATION | Latest Research

490x245Award.png

Awareness Campaign for Largest-Ever Myeloma Study Wins Prestigious Award

The successful marketing and PR campaign that drew the participation of nearly 80,000 Icelanders in the IMF-supported iStopMM project won that country’s highest industry honor, Áran 2017. The team used multiple platforms to raise awareness of the effort to screen adults over 40 for MGUS, the precursor to myeloma.

LearnMoreButton.png

| EDUCATION | Award Recipient

Teresa.jpg

IMF Nurse Leadership Board Member Teresa Miceli Appointed Mayo Associate

The IMF’s Nurse Leadership Board (NLB) member Teresa Miceli, RN BSN OCN (Assistant Professor of Nursing) has been appointed as a Mayo Associate. This outstanding appointment recognizes individuals for their contribution on a continuing basis to the practice, research, and educational activities of their respective department or specialty practice. This recognition is very unique; there are very few nurses who meet the criteria for Associate status.

Teresa was nominated for the Associate appointment by myeloma expert Dr. Morie Gertz (Mayo Clinic), who had previously nominated Teresa to the NLB. “Without his support, I would not be a member of the NLB,” said Teresa. “And every member of the NLB has mentored me and contributed to my receiving this appointment. Activities of the NLB have been integral in bringing me to this level of academic professionalism. A special shout-out goes to NLB’s Dr. Beth Faiman, who has been, and continues to be, a model of professionalism and mentoring. Many thanks to Diane Moran and the International Myeloma Foundation for recognizing the important contribution of nurses to the patient experience.”

LearnMoreButton.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series

DurieVideoBox3.15.18.png

CLINICAL TRIALS

EVENTS

BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board

March 16-17, 2018
IMF Patient & Family Seminar
Boca Raton, FL

April 8, 2018
Julianne’s Rock n’ Roll Half-Marathon
San Francisco, CA

April 21, 2018
IMF Regional Community Workshop
Nashville, TN

April 28, 2018
Miles for Myeloma 5K Walk/Run
Philadelphia, PA

May 5-6, 2018
Miracles Happen When Pigs Fly!
Cincinnati, OH

May 12, 2018
IMF Regional Community Workshop
Seattle, WA

 

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year